Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin-Reference-Cited by-同舟云学术

Clinical and analytical validation of FoundationOne Liquid CDx, a novel 324-Gene cfDNA-based comprehensive genomic profiling assay for cancers of solid tumor origin

Published:2020-09-25 Issue:9 Volume:15 Page:e0237802
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Woodhouse Ryan^ORCID,Li Meijuan,Hughes Jason,Delfosse David,Skoletsky Joel,Ma Pei,Meng Wei,Dewal Ninad,Milbury Coren,Clark Travis,Donahue Amy,Stover Dan,Kennedy Mark,Dacpano-Komansky Jennifer,Burns Christine,Vietz Christine,Alexander Brian,Hegde Priti,Dennis Lucas

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. U.S. Food and Drug Administration anticancer drug approval trends from 2016 to 2018 for lung, colorectal, breast, and prostate cancer;TB Ribeiro;Int J Technol Assess Health Care,2019

2. Oncologist use and perception of large panel next-generation tumor sequencing;AM Schram;Ann Oncol,2017

3. An overview of precision oncology basket and umbrella trials for clinicians;JJH Park;CA Cancer J Clin,2020

4. Molecular profiling of cancer patients enables personalized combination therapy: the I-PREDICT study;JK Sicklick;Nat Med,2019

5. Utility of genomic assessment of blood-derived circulating tumor DNA (ctDNA) in patients with advanced lung adenocarcinoma;MC Schwaederlé;Clin Cancer Res,2017

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Putting comprehensive genomic profiling of ctDNA to work: 10 proposed use cases;The Journal of Liquid Biopsy;2024-06

2. Accurate Detection of Multiple Tumor Mutations in Formalin-Fixed Paraffin-Embedded Tissues by Coupling Sequence Artifacts Elimination and Mutation Enrichment With MeltArray;Laboratory Investigation;2024-02

3. Real-World comprehensive genomic profiling data for diagnostic clarity in pulmonary Large-Cell neuroendocrine carcinoma;Lung Cancer;2024-02

4. Optimizing Accuracy and Efficiency in Analyzing Non-UMI Liquid Biopsy Datasets Using the Sentieon ctDNA Pipeline;2024-01-29

5. Analytical Validation of NeXT Personal^®, an Ultra-sensitive Personalized Circulating Tumor DNA Assay;2024-01-17